Learn About Fragile XE Syndrome

What is the definition of Fragile XE Syndrome?

Fragile XE syndrome is a genetic disorder that impairs thinking ability and cognitive functioning. Most affected individuals have mild intellectual disabilities. In some people with this condition, cognitive function is described as borderline, which means that it is below average but not low enough to be classified as an intellectual disability. Females are rarely diagnosed with fragile XE syndrome, likely because the signs and symptoms are so mild, if present at all.

What are the causes of Fragile XE Syndrome?

Fragile XE syndrome is caused by variants (also called mutations) in the AFF2 gene. This gene provides instructions for making a protein whose function is not well understood. Some studies show that the AFF2 protein can attach (bind) to DNA and help control the activity of other genes. Other studies suggest that the AFF2 protein is involved in the process by which the blueprint for making proteins is cut and rearranged to produce different versions of the protein (alternative splicing). Researchers are working to determine which genes and proteins are affected by AFF2.

How prevalent is Fragile XE Syndrome?

Fragile XE syndrome is estimated to affect 1 in 25,000 to 100,000 newborn males. Because mildly affected individuals may never be diagnosed, it is thought that the condition may be more common than reported.

Is Fragile XE Syndrome an inherited disorder?

Fragile XE syndrome is inherited in an X-linked pattern. A condition is considered X-linked if the altered gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes in each cell. In males (who have only one X chromosome), a variant in the only copy of the gene in each cell is sufficient to cause the condition. In females (who have two copies of the X chromosome), one altered copy of the gene rarely causes the condition and the features are often less severe than in individuals with both copies altered. Some females with only one altered copy of the gene may have no signs or symptoms at all. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

Who are the top Fragile XE Syndrome Local Doctors?
3400 Quadrangle Blvd, 
Orlando, FL 
 (48.0 mi)
Languages Spoken:
English, Sign Language
Accepting New Patients
Offers Telehealth

Danish Bhatti is a Neurologist in Orlando, Florida. Dr. Bhatti and is rated as an Experienced provider by MediFind in the treatment of Fragile XE Syndrome. His top areas of expertise are Drug Induced Dyskinesia, Primary Orthostatic Tremor, Parkinson's Disease, Familial Paroxysmal Nonkinesigenic Dyskinesia, and Deep Brain Stimulation. Dr. Bhatti is currently accepting new patients.

Family Medicine
Family Medicine
1701 Se Hillmoor Dr, Suite B9, 
Port Saint Lucie, FL 
 (64.0 mi)
Experience:
17+ years
Languages Spoken:
English, Spanish
Accepting New Patients

Judith Brooks is a Family Medicine provider in Port Saint Lucie, Florida. Dr. Brooks has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Fragile XE Syndrome. Her top areas of expertise are Fragile XE Syndrome, Fragile X Syndrome, Pulmonary Embolism, and Stable Angina. Dr. Brooks is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Family Medicine
Family Medicine

St Lucie Medical Specialists LLC

1700 Se Hillmoor Dr, 
Port Saint Lucie, FL 
 (64.0 mi)
Languages Spoken:
English
Accepting New Patients

Julia Fashner is a Family Medicine provider in Port Saint Lucie, Florida. Dr. Fashner and is rated as an Experienced provider by MediFind in the treatment of Fragile XE Syndrome. Her top areas of expertise are Amblyopia, Indigestion, Fragile X Syndrome, and Fragile XE Syndrome. Dr. Fashner is currently accepting new patients.

What are the latest Fragile XE Syndrome Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: July 17, 2024
Published By: National Institutes of Health